EYEG Historical PE Ratio image   This EYEG PE ratio history page last updated 11/9/2021
EYEG PE History Chart
PeriodPriceAdj. EPSTTMPE
Q2 2021
8/12/2021
1.73-0.39-1.72NA
Q1 2021
5/12/2021
4.03-0.37-1.71NA
Q4 2020
3/25/2021
5.07-0.52-1.77NA
Q3 2020
11/9/2020
3.30-0.44-2.01NA
Q2 2020
8/6/2020
4.00-0.38-2.72NA
Q1 2020
5/6/2020
5.16-0.43-11.34NA
Q4 2019
3/4/2020
5.65-0.76-8.66NA
Q3 2019
11/7/2019
3.76-1.15-19.15NA
Q2 2019
8/8/2019
3.03-9.00-33.75NA
Q1 2019
5/8/2019
3.952.25-40.50NA
Q4 2018
3/1/2019
6.57-11.25-74.25NA
Q3 2018
11/13/2018
6.30-15.75-117.00NA
Q2 2018
8/3/2018
8.37-15.75-155.25NA
Q1 2018
5/11/2018
7.95-31.50-202.50NA
Q4 2017
3/2/2018
8.93-54.00-234.00NA
Q3 2017
11/14/2017
15.98-54.00-265.50NA
Q2 2017
8/7/2017
17.10-63.00-292.50NA
Q1 2017
5/8/2017
28.35-63.00-333.00NA
Q4 2016
2/23/2017
42.15-85.50-339.75NA
Q3 2016
11/2/2016
21.30-81.00-308.25NA
Q2 2016
8/10/2016
30.90-103.50NANA
Q1 2016
5/13/2016
47.10-69.75NANA
Q4 2015
3/29/2016
45.90-54.00NANA
EYEG Historical PE Ratio Chart
Data adjusted for EYEG split history

PeriodPriceAdj. EPSAnnualizedPE
Q2 2021
8/12/2021
1.73-0.39-1.56NA
Q1 2021
5/12/2021
4.03-0.37-1.48NA
Q4 2020
3/25/2021
5.07-0.52-2.08NA
Q3 2020
11/9/2020
3.30-0.44-1.76NA
Q2 2020
8/6/2020
4.00-0.38-1.52NA
Q1 2020
5/6/2020
5.16-0.43-1.72NA
Q4 2019
3/4/2020
5.65-0.76-3.04NA
Q3 2019
11/7/2019
3.76-1.15-4.60NA
Q2 2019
8/8/2019
3.03-9.00-36.00NA
Q1 2019
5/8/2019
3.952.259.000.4
Q4 2018
3/1/2019
6.57-11.25-45.00NA
Q3 2018
11/13/2018
6.30-15.75-63.00NA
Q2 2018
8/3/2018
8.37-15.75-63.00NA
Q1 2018
5/11/2018
7.95-31.50-126.00NA
Q4 2017
3/2/2018
8.93-54.00-216.00NA
Q3 2017
11/14/2017
15.98-54.00-216.00NA
Q2 2017
8/7/2017
17.10-63.00-252.00NA
Q1 2017
5/8/2017
28.35-63.00-252.00NA
Q4 2016
2/23/2017
42.15-85.50-342.00NA
Q3 2016
11/2/2016
21.30-81.00-324.00NA
Q2 2016
8/10/2016
30.90-103.50-414.00NA
Q1 2016
5/13/2016
47.10-69.75-279.00NA
Q4 2015
3/29/2016
45.90-54.00-216.00NA
Quotes delayed 20 minutes

Email EnvelopeFree EYEG Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Eyegate Pharmaceuticals (EYEG) is categorized under the Healthcare sector; to help you further research PE history across stocks, below are some other companies in the same sector:

EYEN PE Ratio History
EYES PE Ratio History
EYPT PE Ratio History
FATE PE Ratio History
FBIO PE Ratio History
FBRX PE Ratio History
FDMT PE Ratio History
FGEN PE Ratio History
FHTX PE Ratio History
FIGS PE Ratio History
On this page we presented the EYEG PE Ratio History information for Eyegate Pharmaceuticals' stock. The average EYEG PE ratio history based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is 0.4. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average EYEG PE ratio history based on this TTM earnings result method is NA. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this EYEG PE ratio history result, against the recent PE: when this page was posted on 11/5/2021, the most recent closing price for EYEG had been 1.95, and the most recent quarterly earnings result, annualized, was 9. Meanwhile, the most recent TTM earnings summed to NA. From these numbers, we calculate the recent EYEG PE on 11/5/2021 based on annualized quarterly EPS was 0.2. Based on EYEG's history, that recent PE is low relative to the historical average, with the recent PE 50.0% lower than the historical average PE across our data set for Eyegate Pharmaceuticals.

For self directed investors doing their due diligence on EYEG or any other given stock, valuation analysis for EYEG can greatly benefit from studying the past earnings and resulting PE ratio history calculations. This type of study can help inform an analysis as to whether the earnings trajectory over time and current versus historical average PE ratios justify the current stock market value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate Eyegate Pharmaceuticals PE ratio history — or the PE history for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for next earnings dates and also historical earnings surprises history for EYEG. Thanks for visiting, and the next time you need to research EYEG PE Ratio History or the PE ratio history for another stock, we hope our site will come to mind as your go-to PE ratio history research resource of choice.
 

EYEG PE Ratio History | www.HistoricalPERatio.com | Copyright © 2020 - 2021, All Rights Reserved

Nothing in HistoricalPERatio.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.